Pioglitazone promotes preadipocyte proliferation by downregulating p16Ink4a
Authors:
- Arif U. HasanAHArif U. Hasan
- Koji OhmoriKOKoji Ohmori
- 1 July 2011
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 411 (2) , 375-380
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (20500422)
- Kagawa University
This publication has 25 references indexed in Scilit:
- Fighting Fat with Fat: The Expanding Field of Adipose Stem CellsCell Stem Cell, 2009
- Dynamics of fat cell turnover in humansNature, 2008
- Beneficial Effects of Subcutaneous Fat Transplantation on MetabolismCell Metabolism, 2008
- Transcriptional control of adipocyte formationCell Metabolism, 2006
- ThiazolidinedionesNew England Journal of Medicine, 2004
- PPARs and the complex journey to obesityNature Medicine, 2004
- Molecular Mechanism of Insulin Resistance and ObesityExperimental Biology and Medicine, 2003
- Effects of Pioglitazone on Adipose Tissue Remodeling Within the Setting of Obesity and Insulin ResistanceDiabetes, 2001
- CDK inhibitors: positive and negative regulators of G1-phase progressionGenes & Development, 1999
- Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.Journal of Clinical Investigation, 1998